'Dishman Group' is not a separate legal entity but nomenclature used in generality for Dishman Pharmaceuticals and Chemicals Limited the flagship Company and its Indian and foreign subsidiaries joint ventures and associate companies across the globe. All these entities are individual and separate by the law.

Dishman is a global dynamic group of companies offering a continuum of services to the pharmaceutical industry. We are a global outsourcing partner for pharmaceutical companies offering a portfolio of products and development scale-up and manufacturing services.

The Dishman Group continually invests in the pharmaceutical industry ensuring Dishman’s businesses can provide pharmaceutical customers with high-value high-quality products and services today and in the future.

Our focus is to add value to the global pharmaceutical industry by serving as a reliable partner. Our business is successful only when our customers are successful.

CARBOGEN AMCIS is a leading provider of drug development and commercialization services to the pharmaceutical and biopharmaceutical industries at all stages of drug development. The integrated services of CARBOGEN AMCIS provide innovative timely and safe drug development solutions that allow customers to make the best use of their available resources.

CARBOGEN AMCIS’ focus is on supporting the development process from bench to market. The breadth of capabilities spans from contract chemical process researchand development to the supply of Active Pharmaceutical Ingredients (APIs) and drug products for preclinical studies clinical trials and commercial use.

CARBOGEN AMCIS also conducts the development and supply of highly potent APIsto an activity level below 1.0 µg/m³.